Francesca Ambrosio

Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial

Marcello Tiseo, Luca Boni, Francesca Ambrosio et al. · Journal of Clinical Oncology · 2017 · 182 citations

Cancer Management, Pathology, Arm B +17

Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples

Francesco Pepe, Caterina De Luca, Riccardo Smeraglio et al. · Journal of Clinical Pathology · 2018 · 43 citations

Tear-Based Vibrational Spectroscopy Applied to Amyotrophic Lateral Sclerosis

Diletta Ami, Alessandro Duse, Paolo Mereghetti et al. · Analytical Chemistry · 2021 · 37 citations · Full text

Engineering, Neurological Disorder, Biomedical Engineering +23

Neutrophil-to-Lymphocyte Ratio Is a Major Prognostic Factor in Non-small Cell Lung Carcinoma Patients Undergoing First Line Immunotherapy With Pembrolizumab

Francesco Jacopo Romano, Riccardo Ronga, Francesca Ambrosio et al. · Cancer Diagnosis & Prognosis · 2022 · 26 citations · Full text

EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: a validation study

Umberto Malapelle, Caterina De Luca, Elena Vigliar et al. · Journal of Clinical Pathology · 2016 · 24 citations

Cancer Pathology, Paucicellular Smear, Genetics +23